Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification

Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study

(2014) Mohammed A. Aleskandarany et al.   BREAST CANCER RESEARCH AND TREATMENT

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups

(2010) Mohammed A. Aleskandarany et al.   BREAST CANCER RESEARCH AND TREATMENT

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

(2009) Grace M Callagy et al.   BMC CANCER

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis

(2009) Mohammed A. Aleskandarany et al.   BREAST CANCER RESEARCH AND TREATMENT

The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer

(2009) H. Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

(2009) E. A. Rakha et al.   CLINICAL CANCER RESEARCH

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast

(2009) E.A. Rakha et al.   EUROPEAN JOURNAL OF CANCER

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer

(2008) Abdulkader Albasri et al.   JOURNAL OF PATHOLOGY